Company

BioGaia AB

Headquarters: Stockholm, Sweden

Employees: 167

CEO: Ms. Isabelle Valerie Ghislaine Ducellier

OMX: BIOG.B

Market Cap

kr12.57 Billion

SEK as of July 1, 2024

US$1.18 Billion

Market Cap History

BioGaia AB market capitalization over time

Evolution of BioGaia AB market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BioGaia AB

Detailed Description

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates in Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. The company offers its products under the brand name of BioGaia. The company was founded in 1990 and is headquartered in Stockholm, Sweden.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

BioGaia AB has the following listings and related stock indices.


Stock: OMX: BIOG.B wb_incandescent

Stock: FSX: BGL wb_incandescent

Stock: OTC: BIOGY wb_incandescent

Details

Headquarters:

Kungsbroplan 3

Stockholm, 112 27

Sweden

Phone: 46 8 55 52 93 00